Skip Navigation



eCAM Advance Access published online on September 22, 2009

eCAM, doi:10.1093/ecam/nep147
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wang, Y.-C.
Right arrow Articles by Lin, C.-K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.-C.
Right arrow Articles by Lin, C.-K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author(s) 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

In vitro activity of 2-methoxy-1,4-naphthoquinone and stigmasta-7,22-diene-3β-ol from Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori

Yuan-Chuen Wang1, Wan-Yu Li1, Deng-Chyang Wu2,3, Jeh-Jeng Wang4, Cheng-Hsun Wu1, Jyun-Ji Liao1 and Cheng-Kun Lin5

1Department of Food Science and Biotechnology, National Chung Hsing University, Taichung, 2Division of Gastroenterology, Department of Internal Medicine, 3Graduate Institute of Healthcare Administration, College of Health Sciences, 4Faculty of Medicinal and applied Chemistry, Kaoshing Medical University, Kaohsiung and 5Department of Chemistry, National Chung Hsing University, Taichung, Taiwan, R.O.C.

Infection with Helicobacter pylori is strongly associated with gastric cancer and gastric adenocarcinoma. WHO classified H. pylori as a group 1 carcinogen in 1994. Impatiens balsamina L. has been used as indigenous medicine in Asia for the treatment of rheumatism, fractures and fingernail inflammation. In this study, we isolated anti-H. pylori compounds from this plant and investigated their anti- and bactericidal activity. Compounds of 2-methoxy-1,4-naphthoquinone (MeONQ) and stigmasta-7,22-diene-3β-ol (spinasterol) were isolated from the pods and roots/stems/leaves of I. balsamina L., respectively. The minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) for MeONQ were in the ranges of 0.156–0.625 and 0.313–0.625 µg ml–1, respectively, and in the ranges of 20–80 µg ml–1 both of MICs and MBCs for spinasterol against antibiotic (clarithromycin, metronidazole and levofloxacin) resistant H. pylori. Notably, the activity of MeONQ was equivalent to that of amoxicillin (AMX). The bactericidal H. pylori action of MeONQ was dose-dependent. Furthermore, the activity of MeONQ was not influenced by the environmental pH values (4–8) and demonstrated good thermal (121°C for 15 min) stability. MeONQ abounds in the I. balsamina L. pod at the level of 4.39% (w/w db). In conclusion, MeONQ exhibits strong potential to be developed as a candidate agent for the eradication of H. pylori infection.

Keywords: anti-Helicobacter pylori activity – antibiotic resistance – Impatiens balsamina L. – 2-methoxy-1,4-naphthoquinone – spinasterol


For reprints and all correspondence: Dr. Yuan-Chuen Wang, Department of Food Science and Biotechnology, National Chung Hsing University, 250 Kuo-Kuang Rd., Taichung, Taiwan, R.O.C. Tel: +886-4-2284-0385, ext.: 4220; Fax: +886-4-2285-4053; E-mail: ycwang{at}nchu.edu.tw

Received April 22, 2009; accepted August 30, 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.